Principal Financial Group Inc. Grows Position in Imperva Inc (IMPV)
Principal Financial Group Inc. increased its position in Imperva Inc (NASDAQ:IMPV) by 51.7% during the third quarter, according to its most recent Form 13F filing with the SEC. The fund owned 7,067 shares of the software maker’s stock after buying an additional 2,409 shares during the period. Principal Financial Group Inc.’s holdings in Imperva were worth $307,000 at the end of the most recent reporting period.
Other large investors have also recently added to or reduced their stakes in the company. ETF Managers Group LLC acquired a new position in Imperva during the second quarter valued at approximately $41,888,000. BlackRock Inc. grew its holdings in Imperva by 11.3% during the second quarter. BlackRock Inc. now owns 2,124,043 shares of the software maker’s stock valued at $101,635,000 after purchasing an additional 215,170 shares during the last quarter. Eagle Asset Management Inc. grew its holdings in Imperva by 17.7% during the second quarter. Eagle Asset Management Inc. now owns 1,279,848 shares of the software maker’s stock valued at $61,240,000 after purchasing an additional 192,625 shares during the last quarter. Quantitative Investment Management LLC acquired a new position in Imperva during the second quarter valued at approximately $8,546,000. Finally, American Century Companies Inc. acquired a new position in Imperva during the third quarter valued at approximately $6,832,000. Hedge funds and other institutional investors own 96.95% of the company’s stock.
Several brokerages have commented on IMPV. KeyCorp reiterated a “hold” rating on shares of Imperva in a report on Tuesday, October 24th. Imperial Capital lowered their price target on Imperva from $57.00 to $50.00 and set an “outperform” rating on the stock in a report on Tuesday, October 10th. BidaskClub upgraded Imperva from a “sell” rating to a “hold” rating in a report on Tuesday, September 12th. Evercore ISI reiterated a “buy” rating and set a $56.00 price target on shares of Imperva in a report on Wednesday, November 8th. Finally, Oppenheimer reiterated a “buy” rating and set a $55.00 price target on shares of Imperva in a report on Thursday, November 9th. Three research analysts have rated the stock with a sell rating, seven have issued a hold rating, nine have issued a buy rating and one has given a strong buy rating to the company. The company presently has an average rating of “Hold” and an average price target of $51.86.
Imperva (NASDAQ:IMPV) last announced its quarterly earnings data on Wednesday, November 8th. The software maker reported $0.33 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.22 by $0.11. The business had revenue of $83.89 million for the quarter, compared to the consensus estimate of $83.79 million. Imperva had a net margin of 3.04% and a negative return on equity of 8.52%. Imperva’s quarterly revenue was up 22.6% on a year-over-year basis. During the same quarter last year, the company posted $0.08 earnings per share. analysts anticipate that Imperva Inc will post -0.52 earnings per share for the current fiscal year.
ILLEGAL ACTIVITY WARNING: “Principal Financial Group Inc. Grows Position in Imperva Inc (IMPV)” was originally published by The Cerbat Gem and is owned by of The Cerbat Gem. If you are accessing this story on another domain, it was stolen and reposted in violation of US and international trademark & copyright laws. The original version of this story can be read at https://www.thecerbatgem.com/2017/12/17/principal-financial-group-inc-grows-position-in-imperva-inc-impv.html.
Imperva, Inc provides cyber-security solutions that protect business-critical data and applications whether in the cloud or on premises. The Company is engaged in the development, marketing, sales, service and support of cyber-security solutions. The Company’s products include its Imperva SecureSphere Paltform, Imperva CounterBreach and Imperva Camouflage for enterprise data centers, and Imperva Incapsula offering for cloud-based security services.
Receive News & Stock Ratings for Imperva Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Imperva and related stocks with our FREE daily email newsletter.